Compile Data Set for Download or QSAR
Report error Found 9 Enz. Inhib. hit(s) with all data for entry = 11472
TargetGlucocorticoid receptor(Human)
Regeneron Pharmaceuticals

US Patent
LigandPNGBDBM618700(US11760775, Compound 4b)
Affinity DataIC50: 10nMAssay Description:To evaluate the ability of novel steroids to bind to the Glucocorticoid Receptor (GR), a cell-free binding assay was performed using a LanthaScreen T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Regeneron Pharmaceuticals

US Patent
LigandPNGBDBM618703(US11760775, Compound R-6-I)
Affinity DataIC50: 10nMAssay Description:To evaluate the ability of novel steroids to bind to the Glucocorticoid Receptor (GR), a cell-free binding assay was performed using a LanthaScreen T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Regeneron Pharmaceuticals

US Patent
LigandPNGBDBM618704(US11760775, Compound S-6-I)
Affinity DataIC50: 10nMAssay Description:To evaluate the ability of novel steroids to bind to the Glucocorticoid Receptor (GR), a cell-free binding assay was performed using a LanthaScreen T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Regeneron Pharmaceuticals

US Patent
LigandPNGBDBM618705((1S,2S,4R,8S,9S,11S,12R,13S,19S)-8-{2-[4-Amino(2,3...)
Affinity DataIC50: 10nMAssay Description:To evaluate the ability of novel steroids to bind to the Glucocorticoid Receptor (GR), a cell-free binding assay was performed using a LanthaScreen T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Regeneron Pharmaceuticals

US Patent
LigandPNGBDBM618706(US11760775, Compound 6-II)
Affinity DataIC50: 10nMAssay Description:To evaluate the ability of novel steroids to bind to the Glucocorticoid Receptor (GR), a cell-free binding assay was performed using a LanthaScreen T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Regeneron Pharmaceuticals

US Patent
LigandPNGBDBM618707(US11760775, Compound 6-VII)
Affinity DataIC50: 10nMAssay Description:To evaluate the ability of novel steroids to bind to the Glucocorticoid Receptor (GR), a cell-free binding assay was performed using a LanthaScreen T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Regeneron Pharmaceuticals

US Patent
LigandPNGBDBM50354850(BUDESONIDE | US10869929, Compound Budesonide | US1...)
Affinity DataIC50: 30nMAssay Description:To evaluate the ability of novel steroids to bind to the Glucocorticoid Receptor (GR), a cell-free binding assay was performed using a LanthaScreen T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Regeneron Pharmaceuticals

US Patent
LigandPNGBDBM618701(US11760775, Compound 4d)
Affinity DataIC50: 30nMAssay Description:To evaluate the ability of novel steroids to bind to the Glucocorticoid Receptor (GR), a cell-free binding assay was performed using a LanthaScreen T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Regeneron Pharmaceuticals

US Patent
LigandPNGBDBM618702(US11760775, Compound 4h)
Affinity DataIC50: 30nMAssay Description:To evaluate the ability of novel steroids to bind to the Glucocorticoid Receptor (GR), a cell-free binding assay was performed using a LanthaScreen T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/29/2023
Entry Details
Go to US Patent